BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11599525)

  • 41. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.
    Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL
    Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kidney function after the intraoperative use of 6% tetrastarches (HES 130/0.4 and 0.42).
    Ishihara H
    J Anesth; 2014 Apr; 28(2):249-56. PubMed ID: 24104945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroxyethyl starch 130/0.4 and postoperative acute kidney injury.
    Groeneveld AB; Navickis RJ; Wilkes MM
    Anesthesiology; 2013 Sep; 119(3):733-5. PubMed ID: 23962942
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of Hydroxyethyl Starch on Acute Kidney Injury After Living Donor Hepatectomy.
    Kim SK; Choi SS; Sim JH; Baik J; Hwang S; Lee SG; Kim YK
    Transplant Proc; 2016; 48(1):102-6. PubMed ID: 26915851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent U.S. Food and Drug Administration Labeling Changes for Hydroxyethyl Starch Products Due to Concerns about Mortality, Kidney Injury, and Excess Bleeding.
    Landow L; Wei S; Song L; Goud R; Cooper K
    Anesthesiology; 2022 May; 136(5):868-870. PubMed ID: 35258516
    [No Abstract]   [Full Text] [Related]  

  • 46. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.
    Wiedermann CJ
    Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021
    [No Abstract]   [Full Text] [Related]  

  • 47. Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery.
    McConnell M; Baisden J; Duncan AE
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):570-575. PubMed ID: 29174121
    [No Abstract]   [Full Text] [Related]  

  • 48. Hydroxyethylstarch solutions versus saline for the treatment of intradialytic hypotension.
    Konings M; Wolters E; Betjes MG
    J Ren Care; 2007; 33(3):130-3. PubMed ID: 19160885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravascular volume therapy with colloids in cardiac surgery.
    Lange M; Ertmer C; Van Aken H; Westphal M
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):847-55. PubMed ID: 20709570
    [No Abstract]   [Full Text] [Related]  

  • 50. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
    Dart AB; Mutter TC; Ruth CA; Taback SP
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007594. PubMed ID: 20091640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?
    Hartog CS; Brunkhorst FM; Engel C; Meier-Hellmann A; Ragaller M; Welte T; Kuhnt E; Reinhart K;
    Wien Klin Wochenschr; 2011 Mar; 123(5-6):145-55. PubMed ID: 21359642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excessive use of hetastarch: An iatrogenic cause of bleeding and hypocalcemia?
    Haynes GR; Bailey MK
    Anesth Analg; 2000 Jun; 90(6):1455-6. PubMed ID: 10825341
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of 6% hydroxyethyl starch and 5% albumin for volume replacement therapy in patients undergoing cystectomy (CHART): study protocol for a randomized controlled trial.
    Kammerer T; Klug F; Schwarz M; Hilferink S; Zwissler B; von Dossow V; Karl A; Müller HH; Rehm M
    Trials; 2015 Aug; 16():384. PubMed ID: 26314293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
    Mills GH
    Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of Hydroxyethyl Starch Solution on Incidence of Acute Kidney Injury in Patients Suffering from Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage.
    Kieninger M; Unbekannt D; Schneiker A; Sinner B; Bele S; Prasser C
    Neurocrit Care; 2017 Feb; 26(1):34-40. PubMed ID: 27059048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.
    Mutter TC; Ruth CA; Dart AB
    Cochrane Database Syst Rev; 2013 Jul; (7):CD007594. PubMed ID: 23881659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxyethyl starch 130/0.4: safe for the kidney in surgical patients?
    Wiedermann CJ
    Anesthesiology; 2013 Sep; 119(3):735-6. PubMed ID: 23962943
    [No Abstract]   [Full Text] [Related]  

  • 58. Hydroxyethylstarch-associated transient acute renal failure after epidural anaesthesia for labour analgesia and Caesarean section.
    Dickenamm MJ; Filipovic M; Schneider MC; Brunner FP
    Nephrol Dial Transplant; 1998 Oct; 13(10):2706. PubMed ID: 9794598
    [No Abstract]   [Full Text] [Related]  

  • 59. Is Hydroxyethyl Starch 130/0.4 Safe for the Kidney in Noncardiac Surgical Patients?
    Xue FS; Cui XL; Wang SY
    Anesthesiology; 2015 Aug; 123(2):481-2. PubMed ID: 26196876
    [No Abstract]   [Full Text] [Related]  

  • 60. The nephrotoxicity of 6% Hydroxyethyl Starch 130/0.4 in surgery.
    Kancir AS
    Acta Anaesthesiol Scand; 2016 Apr; 60(4):548-9. PubMed ID: 26941118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.